Vir Biotechnology (VIR) Other Accumulated Expenses (2018 - 2023)

Vir Biotechnology's Other Accumulated Expenses history runs 6 years deep, the most recent figure standing at $9.7 million for Q1 2023.

• In Q1 2023, Other Accumulated Expenses fell 44.62% year-over-year to $9.7 million; the TTM figure through Mar 2023 stood at $9.7 million (down 44.62% YoY), while the FY2022 annual figure was $12.7 million, up 23.96% from the prior year.
• Other Accumulated Expenses came in at $9.7 million for Q1 2023 at Vir Biotechnology, down from $12.7 million in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $21.4 million in Q3 2022 to a low of $595000.0 in Q2 2020.
• A 5-year average of $7.0 million and a median of $3.3 million in 2021 frame the typical range for Other Accumulated Expenses.
• Across the five-year window, Other Accumulated Expenses tumbled 56.53% in 2019 and surged 1173.79% in 2021, its largest moves.
• Vir Biotechnology's Other Accumulated Expenses stood at $1.2 million in 2019, then plunged by 30.36% to $805000.0 in 2020, then soared by 1173.79% to $10.3 million in 2021, then advanced by 23.96% to $12.7 million in 2022, then slipped by 23.53% to $9.7 million in 2023.
• According to Business Quant data, Other Accumulated Expenses over the past three periods registered $9.7 million, $12.7 million, and $21.4 million for Q1 2023, Q4 2022, and Q3 2022 respectively.

Peer Comparison